CClinicalTrials.gg
Status unknownNCT03957447WOUNDCAREUpdated Jan 4, 2023

Treat Early and Broad: Thermotherapy of Buruli Ulcer Integrated Into WHO-recommended Wound Management in West Africa

An observational study in Skin Ulcer, Buruli Ulcer and Nontuberculous Mycobacteria, sponsored by University Hospital Heidelberg. Status unknown at 1 site in Côte D'Ivoire. Per ClinicalTrials.gov, last updated 2023-01-04.

Sponsored by University Hospital Heidelberg · Observational

The sponsor has not verified this record recently (last verified Jan 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
5,000
Sex
All
01

Study summary

The project rolls out combined innovative low-tech thermotherapy with heat packs and WHO recommended wound management in a Buruli ulcer (BU)-endemic district of West Africa. It addresses three key areas of considerable clinical and public health importance in the region:

  • to better help people managing the disabling disease BU that primarily affects children in West Africa
  • to implement WHO recommended general wound management for all types of wounds with tools available at the peripheral level of the health care system
  • to prevent systemic life threatening sequelae (e.g. sepsis and rheumatic fever) and permanent local damage (e.g. motor and sensory disability) by early recognition and treatment of wounds at the community level. The project translates available research findings already validated on the secondary health care level into clinical practice at the periphery (primary health care level). The string of the investigator's previous work from the development of the BU thermotherapy-wound management-package to the proof of its efficacy provides all necessary skills, tools and documents to immediately proceed into practical community application.

Operational endpoints are

  • coverage and quality of WHO recommended wound management training of health care personnel at the primary health care level (health posts);
  • coverage, success rate and quality of care for patients with BU and other wounds; denominator controlled at health post level and high-quality Health and Demographic Surveillance Systems (HDSS) data.

The project is embedded into a stable multidisciplinary working environment at Côte d'Ivoire, including an HDSS with a longstanding record of partnership and successful community-based operational research.

The project builds on the principles laid out by the Sustainable Development Goals (SDGs) and Universal Health Coverage (UHC) and

  • targets all patients with a broken down skin barrier independent of the cause (patient centred health care)
  • brings diagnosis and treatment close to the community
  • educates and trains both community members and health care workers
  • measures the health intervention outcome The project is fully in line with the new integrated strategy for the skin NTDs of WHO's Department of Control of NTDs (WHO/NTD).
Read the detailed description

Overall goal of the study To contribute to a better understanding of the clinical epidemiology of wounds and wound healing and to improve wound management in settings with limited resources at the community level, the primary and secondary level of the health care services.

Study objectives Main study

  • To measure the proportion of wounds healed (defined as wound closed) at each cycle of clinical diagnosis and the corresponding presumptive treatment
  • To describe the clinical epidemiology of wounds presented (presumptive clinical and confirmed diagnoses)
  • Coverage and quality of wound management training of health care personnel at the peripheral health care level (health posts); Substudy 1
  • To measure the effectiveness and acceptability of thermotherapy of patients with early BU (\< 2cm) treated at health post level with the following outcomes:

    • Primary endpoints absence of clinically BU specific features' according to WHO guidelines or 'wound closure' within 6 months after completion of heat treatment ("primary cure") and 'absence of BU recurrence for 12 months after completion of heat treatment' ("definite cure").
    • Secondary outcomes rates of withdrawal for low compliance consent withdrawal rating of thermotherapy by health staff Substudy 2
  • To measure the frequency and the severity of skin lesions (broken skin barrier) in the community and the health services
  • To investigate the determining factors of community and health services-based wound management
  • To measure the impact of the wound management intervention (main study and substudy 1) on the frequency, spectrum and severity of wounds including systemic complications in the community and at the 7 health posts / district hospital (HDSS-based) compared to the baseline study before the intervention and over time after the implementation of the intervention.

Target Population The target population are approximately 43,000 people of the Taabo HDSS which is surveyed longitudinally for key demographic, health and socioeconomic indicators since 2008. This provides ideal conditions to implement the intervention and assess the impact through operational endpoints. The health centres and the district hospital involved are part of the public health system. There is one district hospital and the seven health posts within the Taabo DHSS.

02

Conditions studied

  • Skin Ulcer
  • Buruli Ulcer
  • Nontuberculous Mycobacteria

Browse trials for

Keywords

  • skin wounds
  • Ivory Coast community health services
  • prevalence study
  • thermotherapy
03

In context

Skin Ulcer

79 studies on the registry are indexed under Skin Ulcer; 14 are open to participants now.

This study's planned enrollment of 5,000 is above the median of 92 across 10 observational studies indexed under Skin Ulcer.

Browse Skin Ulcer studies →

Lead sponsor

University Hospital Heidelberg is the lead sponsor of 175 studies on the registry; 48 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients in Taabo Health District (HDSS), Ivory Coast Survey All HDSS population members Wound management study Patients with wounds defined as broken skin barrier. Thermotherapy study Buruli ulcer patients of the main study with ulcers \< 2cm.

Inclusion criteria

Survey All HDSS population members Wound management study Patients with wounds defined as broken skin barrier. Thermotherapy study Buruli ulcer patients of the main study with ulcers \< 2cm.

Exclusion criteria

Exclusion Criteria:

none

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
5,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • patients exhibiting skin wounds

    Within the framework of Taabo HDSS Cross-sectional community and health services surveys are performed before wound management intervention (main study and substudy 1) is implemented (baseline) and are continued at 6 monthly intervals thereafter. Surveys are done door-to-door. All patients with skin lesions (broken skin barrier) are enrolled, lesions are documented with help of a questionnaire and photographic documentation.

  • patients identified in the survey and willing to participate

    Each patient with a wound will be enrolled. Presumptive clinical diagnosis and empirical treatment, as well wound assessment, will be recorded at enrollment and at each follow-up visit. Additional laboratory testing done within the framework of the local health system will also be recorded.

  • patients exhibiting Buruli ulcers < 2cm

    Buruli ulcer patients fulfilling inclusion criteria will be offered thermotherapy instead of standard antibiotic treatment. Heat treatment is applied for 42 days plus a safety margin of up to 14 days, if ulcer margins have not fully collapsed and/or induration has not fully subsided. Treatment terminates earlier, if a lesion is completely closed. Thermotherapy will be applied with heat packs twice daily.

    Other: thermotherapy (application of heat): This part of the trial is on hold due to the Covid19-pandemia

Interventions

  • Otherthermotherapy (application of heat): This part of the trial is on hold due to the Covid19-pandemia

    Heat treatment is applied for 42 days plus a safety margin of up to 14 days, if ulcer margins have not fully collapsed and/or induration has not fully subsided. Treatment terminates earlier, if a lesion is completely closed. Thermotherapy will be applied with heat packs twice daily.

06

What researchers measure

Primary outcomes

  1. Prevalence of skin ulcers in inhabitants of the Taabo health district, Ivory Coast

    To measure the frequency and the severity of skin lesions (broken skin barrier) in the community and the health services

    Time frame: 2 years

  2. Qualitative description of factors determining public health services-based skin ulcer managment

    Description of facilitating and obstructive factors for recognition and treatment of ulcers (questionnaires, interviews, patient and institution-related documentation of costs)

    Time frame: 2 years

  3. Frequency and severity of skin ulcers after community health service intervention

    To measure the impact of the wound management intervention (main study and substudy 1) on the frequency, spectrum and severity of wounds including systemic complications in the community and at the health posts / district hospital compared To the baseline study before intervention and over time after implementation of the intervention.

    Time frame: 2 years

  4. Number of patients with healed skin ulcers identified in the survey (see outcome 1)

    To measure the proportion of ulcers healed at each cycle of clinical diagnosis and corresponding presumptive treatment

    Time frame: 2 years

  5. Number of patients presenting at the health posts level with skin ulcers identified in the survey (see above)

    To describe the clinical epidemiology of different types of skin ulcers (wounds) presented (presumptive clinical and confirmed diagnoses)

    Time frame: 2 years

  6. Quality of care for patients with skin ulcers identified in the survey (see above)

    Coverage and quality of skin ulcer (wound) management training of health care personnel at the peripheral health care level (health posts)

    Time frame: 2 years

  7. Outcome of patients with Buruli ulcers < 2cm and willing to participate in thermotherapy study

    Number of patients completing thermotherapy exhibiting no more signs of clinically Buruli ulcer (BU) specific features' according to WHO guidelines or 'wound closure' within 6 months after completion of heat treatment ("primary cure") and 'absence of BU recurrence for 12 months after completion of heat treatment' ("definite cure").

    Time frame: 2 years

Secondary outcomes

  1. Drop out rate of patients with Buruli ulcers < 2cm and willing to participate in thermotherapy substudy

    Number of participants of the thermotherapy substudy not included in analysis of healing rate (see outcome 7) due to lack of cooperation or failure to return for assessment

    Time frame: 2 years

  2. Withdrawal of patients with Buruli ulcers < 2cm and willing to participate in thermotherapy substudy

    Number of participants with consent withdrawal

    Time frame: 2 years

  3. Patients with Buruli ulcers < 2cm and willing to participate in thermotherapy substudy

    Rating of skin ulcer thermotherapy by health staff of the Taabo health distric, Ivory Coast, measured by a score based on a questionnaire

    Time frame: 2 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Toppino S, Koffi DY, Kone BV, N'Krumah RTAS, Coulibaly ID, Tobian F, Pluschke G, Stojkovic M, Bonfoh B, Junghanss T. Community-based wound management in a rural setting of Cote d'Ivoire. PLoS Negl Trop Dis. 2022 Oct 13;16(10):e0010730. doi: 10.1371/journal.pntd.0010730. eCollection 2022 Oct. PubMed 36227844 ↗
  • Toppino S, N'Krumah RTAS, Kone BV, Koffi DY, Coulibaly ID, Tobian F, Pluschke G, Stojkovic M, Bonfoh B, Junghanss T. Skin wounds in a rural setting of Cote d'Ivoire: Population-based assessment of the burden and clinical epidemiology. PLoS Negl Trop Dis. 2022 Oct 13;16(10):e0010608. doi: 10.1371/journal.pntd.0010608. eCollection 2022 Oct. PubMed 36227839 ↗

Individual participant data

Plan to share: Undecided — A RedCap datashare platform is in place already. Individual patient data will be provided anonymised.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 4, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03957447
Lead sponsor
University Hospital Heidelberg
Collaborators
Centre Suisse de Recherches Scientifiques en Cote d'Ivoire, Institut Pasteur de Côte d'Ivoire, Abidjan Cocody CHU, Côte d'Ivoire
Responsible party
Martin Koch (Medical Writer/Data Entry Supervisor, University Hospital Heidelberg) — Principal investigator
First posted
May 21, 2019
Start date
May 7, 2019
Primary completion
Jun 30, 2024 (estimated)
Completion
Sep 30, 2024 (estimated)
Last update
Jan 4, 2023

Study contacts

Bassirou Bonfoh, PhD
Contact
mailto:bassirou.bonfoh@csrs.ci
+22507078083
Thomas Junghanss, MD
Contact
Thomas.Junghanss@urz.uni-heidelberg.de
+491634270831
Marija Stojkovic, MD
principal investigator · University Hospital Heidelberg, Germany

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion